“It is important to note that each time a licensing agreement is concluded the licensee conducts an extensive programme of due diligence particulary on BioProgress patents. It is understood that FMC Corporation for example in addition to its own internal patent department employed no less than five firms of patent attorneys to scrutinise the BioProgress patent portfolio. This rigorous due diligence......is supportive to the company’s case.”
If they draft the claims as many times as the LemmingInterview I’m sure they’ll eventually satisfy the patent examiner;-) They haven’t come this far to get tripped up at the last hurdle.....